WALL STREET ASSOCIATES - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 38 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$1,385,000
+76.7%
170,4000.0%0.47%
+50.3%
Q2 2016$784,000
+10.3%
170,4000.0%0.31%
+6.4%
Q1 2016$711,000
-46.1%
170,4000.0%0.30%
-20.5%
Q4 2015$1,319,000
-40.3%
170,4000.0%0.37%
-12.3%
Q3 2015$2,210,000
-24.2%
170,400
-11.4%
0.42%
+53.8%
Q2 2015$2,915,000192,4000.28%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 225,000$3,409,0003.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$56,546,0001.88%
RA Capital Management 757,263$11,473,0001.15%
Rock Springs Capital Management LP 564,358$8,550,0000.62%
Monashee Investment Management LLC 62,500$947,0000.45%
SPHERA FUNDS MANAGEMENT LTD. 255,000$3,863,0000.38%
WALL STREET ASSOCIATES 192,400$2,915,0000.28%
Ghost Tree Capital, LLC 50,000$758,0000.25%
SABBY MANAGEMENT, LLC 430,041$6,515,0000.24%
Endurant Capital Management LP 46,500$704,0000.21%
View complete list of NIVALIS THERAPEUTICS INC shareholders